Stock 6589 EIRGENIX INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company EirGenix Inc.

Equities

6589

TW0006589005

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-06-11 pm EDT 		5-day change 1st Jan Change
84.5 TWD -2.09% Intraday chart for EirGenix Inc. +5.62% -15.92%
May. 15 EirGenix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 22 EirGenix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

EirGenix Inc is a Taiwan-based company primarily engaged in the development of antibody drugs and the manufacture of biopharmaceuticals. Its main businesses include the provision of Contract Development & Manufacturing Organization (CDMO) services, the construction of cell strain, the manufacture of clinical trial medicine, analytical science and protein identification, and PIC/S manufacturing plant to provide clinical trial drug production.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Biotechnology Drugs
100.0 %
1,481 100.0 % 1,023 100.0 % -30.95%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
46.4 %
747 50.4 % 474 46.4 % -36.52%
Europe
23.7 %
283 19.1 % 242 23.7 % -14.52%
Japan
18.2 %
133 9.0 % 187 18.2 % +40.26%
United States and Canada
11.7 %
305 20.6 % 119 11.7 % -60.88%
Others
0.0 %
13 0.9 % 0 0.0 % -96.37%

Managers

Managers TitleAgeSince
Li Cheng Liu CEO
 Chief Executive Officer - 12-12-20
Hsiu Chuan Yang DFI
 Director of Finance/CFO - 16-05-02
Chih Jung Chang COO
 Chief Operating Officer - 13-03-31

Members of the board

Members of the board TitleAgeSince
Chih Lung Shen BRD
 Director/Board Member 59 21-12-05
Cheng Yue Cheng BRD
 Director/Board Member - 13-06-13
Ming Hsien Chen BRD
 Director/Board Member - 16-09-12
Fu Shiow Yin BRD
 Director/Board Member - -
Fu Hsiu Yin BRD
 Director/Board Member - 16-09-12
Chung Ho Liu CHM
 Chairman - 13-06-13
Hsiu Hui Chen BRD
 Director/Board Member - 16-09-12
Li Cheng Liu CEO
 Chief Executive Officer - 12-12-20
Wei Hung Chang BRD
 Director/Board Member - 19-12-22
Wei Feng Kao BRD
 Director/Board Member - 22-04-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 306,109,214 186,714,214 ( 61.00 %) 0 61.00 %

Shareholders

NameEquities%Valuation
Mega International Investment Trust Co., Ltd.
0.0624 %
190,999 0.0624 % 473 458 NT$

Company contact information

EirGenix, Inc.

Kangning Street 101, Lane 169

221 80, New Taipei

+

http://www.eirgenix.com
address EirGenix Inc.(6589)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Ratings for EirGenix Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
84.5 TWD
Average target price
112.5 TWD
Spread / Average Target
+33.14%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
EIRGENIX INC. Stock EirGenix Inc.
-15.92% 802M
CSL LIMITED Stock CSL Limited
+0.46% 91.38B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-2.37% 38.68B
UCB Stock UCB
+71.42% 27.84B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-12.31% 16.05B
INCYTE CORPORATION Stock Incyte Corporation
-4.54% 13.48B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-10.83% 11.73B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+180.20% 10.74B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-48.60% 10.39B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+1.42% 8.94B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 6589 Stock
  4. Company EirGenix Inc.